- GAPP Investment Strategy
- GAPP Expression of Interest Form (September 2018)
- GAPP Supplementary Proposal Form (April 2018)
- GAPP Resubmission of Supplementary Proposal Form (April 2018)
The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations, and are co-funded by Genome Canada, Receptors and other stakeholders.
To be eligible for GAPP funding, projects must:
- develop and apply a genomics-derived tool, product or process to an opportunity or need defined by the Receptor(s);
- focus on late stage R&D that will position the innovation for near term implementation / commercialization;
- be co-led by an Academic and a Receptor organization in partnership, with active and necessary roles for both (see GAPP Investment Strategy and Guidelines for GAPP project partner definitions); and,
- have the potential to generate significant social and/or economic benefits for Canada (see Section 6 for description of benefits to Canada).
Applicants can request up to 1/3 of the project budget from Genome Canada, from a minimum contribution of $100,000 to a maximum of $2 million. The remaining project funding must be secured from other eligible sources, with at least 1/3 provided by the Receptor(s). The duration of GAPP projects should be a minimum of one year to a maximum of three years, but may be shorter or longer if justified.
All applications to GAPP must be submitted via a regional Genome Centre. Please contact your regional Genome Centre for more information.